Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Actúa sobre la hormona GLP-1 y consigue similares resultados que los inyectables de Novo Nordisk (Ozempic) y Eli Lilly ...

El auge de los medicamentos GLP-1 para perder peso representa un cambio en la forma en que los consumidores abordan sus ...

Chrissy Metz opened up about the secrets behind her 100-pound weight loss while addressing Ozempic and gastric bypass surgery rumors. The This Is Us alum, 44, said she’s become “consistent ...

Ian Randall is Newsweek's Deputy Science Editor, based in Royston, U.K. His focus is reporting on science and health. He has covered archeology, geology, and physics extensively. Ian joined ...

If you’re currently taking a prescription weight loss medication such as Ozempic, Wegovy, Saxenda or Zepbound (or you’re considering taking one), you likely already know that it’s still important to ...

There were some weird things left in Ubers last year — and nowhere were passengers more forgetful than in New York City, new data shows. Newark, New Jersey, wasn't far behind, at eighth on the ...

(Lancet Diabetes & Endocrinology) Five scientists who helped develop the blockbuster diabetes and weight-loss drug semaglutide (Ozempic, Wegovy) are among the recipients of the 2025 Breakthrough ...

According to The New York Times, the drug is particularly prevalent along a stretch of Manhattan from the Upper East Side down to Gramercy Park, where people are taking Ozempic, Wegovy or Mounjaro ...

SAO PAULO, 7 abr (Reuters) - Novo Nordisk, el productor de Ozempic, Wegovy y otros medicamentos, invertirá 6.400 millones de reales (1.090 millones de dólares) en Brasil para impulsar su ...

The drug semaglutide, found in popular brands like Wegovy and Ozempic, looks especially promising in lowering the chances of memory problems, a hallmark of dementia. The study looked at nearly ...

1:54 GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer’s risk for those with diabetes Two major studies published Monday in JAMA Neurology found that GLP-1 medications are linked to a lower risk ...